Search Results - "Pandit-Taskar N"

Complete remission of relapsed ATXN2L::JAK2 fusion positive anaplastic large cell lymphoma following ruxolitinib monotherapy in a child.

Authors: Cohen T Zhou T Edema U et al.

Source: NPJ precision oncology [NPJ Precis Oncol] 2026 Feb 14; Vol. 10 (1). Date of Electronic Publication: 2026 Feb 14.

Publication Type: Journal Article

Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Diagnostic Role and Clinical Impact of Zr-Girentuximab PET-CT for the Diagnosis and Treatment of Clear-Cell Renal Cell Carcinoma.

Authors: González-Padilla, Daniel A. Villacampa-Auba, Felipe Caño-Velasco, Jorge et al.

Source: Diagnostics (2075-4418). May2026, Vol. 16 Issue 9, p1323. 10p.

Early Detection of Neuroblastoma Recurrence on 18 F m FBG PET.

Authors: Pandit-Taskar N Price A Behr G et al.

Source: Clinical nuclear medicine [Clin Nucl Med] 2026 Jul 01; Vol. 51 (7), pp. 580-582. Date of Electronic Publication: 2026 Feb 09.

Publication Type: Journal Article; Case Reports

Journal Info: Publisher: Lippincott Country of Publication: United States NLM ID: 7611109 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-0229 (Electronic) Linking ISSN: 03639762 NLM ISO Abbreviation: Clin Nucl Med Subsets: MEDLINE

Pediatric PET/MRI: Imaging Techniques, Indications, and Clinical Implementation.

Authors: Gatidis S Ponisio MR Borgwardt L et al.

Source: Radiographics : a review publication of the Radiological Society of North America, Inc [Radiographics] 2025 Nov; Vol. 45 (11), pp. e240105.

Publication Type: Journal Article; Review

Journal Info: Publisher: Radiological Society of North America Country of Publication: United States NLM ID: 8302501 Publication Model: Print Cited Medium: Internet ISSN: 1527-1323 (Electronic) Linking ISSN: 02715333 NLM ISO Abbreviation: Radiographics Subsets: MEDLINE

Digital Twins for Radiopharmaceutical Dosimetry: PBPK Modelling of [ 177 Lu]Lu-rhPSMA-10.1 in a Preclinical mCRPC Model.

Authors: Costa, Gustavo Yousefzadeh-Nowshahr, Elham Vasic, Valentina et al.

Source: Cancers. Dec2025, Vol. 17 Issue 24, p3957. 13p.

Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma.

Authors: Hebron, Katie E. Odeniyide, Patience Wei, Yun et al.

Source: Cancers. Mar2026, Vol. 18 Issue 6, p888. 31p.

Uptake Patterns of [ 18 F]Fluoroestradiol PET/MRI in Benign Breast Lesions and Molecular Breast Cancer Subtypes.

Authors: Spiegel, Thomas Rasul, Sazan Pötsch, Nina et al.

Source: Cancers. Feb2026, Vol. 18 Issue 4, p696. 14p.

Utilizing [ 18 F]-FDG PET/CT Imaging for Enhanced Staging and Treatment Decisions in Pediatric Rhabdomyosarcoma.

Authors: Halalsheh, Hadeel Odeh, Nada Kiswani, Arwa et al.

Source: Cancers. May2026, Vol. 18 Issue 10, p1629. 14p.

Highlight selection of radiochemistry and radiopharmacy developments by editorial board.

Authors: Toyohara, Jun Elsinga, Philipp H. Todde, Sergio et al.

Source: EJNMMI Radiopharmacy & Chemistry. 10/3/2025, Vol. 10 Issue 1, p1-16. 16p.

Integration of PSMA-Targeted Theranostics into Multidisciplinary Care for Improved Efficiencies and Patient Care.

Authors: Kuo, Phillip H. Poku, Erasmus Kofi Yamauchi, Dave M. et al.

Source: Journal of Nuclear Medicine Technology. Dec2025, Vol. 53 Issue 4, p300-304. 5p.

Sestrin3 confers resistance to recombinant human arginase in small cell lung cancer by activating Akt/mTOR/ASS1 axis.

Authors: Zhang, Zhongqiang Lin, Zizhe Li, Weishan et al.

Source: PLoS ONE. 12/29/2025, Vol. 20 Issue 12, p1-17. 17p.

Metabolic [¹⁸F]F-AraG PET imaging of T Cell activation: a functional complement to cell-specific immune tracers.

Authors: Almutairi, Waleed M. Gopaulchan, Matthew Bhaskara, Rashmi et al.

Source: EJNMMI Research. 4/19/2026, Vol. 16 Issue 1, p1-17. 17p.

Bimodal Fluorescent Conjugate Based on Prostate-Specific Membrane Antigen Ligands with the Chelating Agent DOTA and SulfoCy5 Dye: Synthesis, Radiolabeling, and Biological Activity.

Authors: Machulkin, Aleksei E. Petrov, Stanislav A. Butakova, Nina S. et al.

Source: International Journal of Molecular Sciences. Apr2026, Vol. 27 Issue 8, p3502. 18p.

Age-Stratified Imaging Selection in Langerhans Cell Histiocytosis: Towards a Clinical Decision Framework.

Authors: Gettleman, Brandon Jeong, Sumin Joachim, Kole et al.

Source: Journal of Clinical Medicine. Apr2026, Vol. 15 Issue 7, p2568. 13p.

The Role of Radiological Imaging in Assessing Risk Factors for Physical Disability: A Scoping Review.

Authors: Yousef, Mohamed Zumrawi, Ebtisam Elamin, Abubaker Y. et al.

Source: Journal of Disability Research. 2026, Vol. 5 Issue 1, p1-13. 13p.

[ 161 Tb]Tb-BPAMD as a High-Affinity Agent for Skeletal Targeting: Radiochemical and Biodistribution Insights.

Authors: Radović, Magdalena Sitarica, Pavle Stanković, Dragana et al.

Source: Pharmaceutics. Mar2026, Vol. 18 Issue 3, p312. 15p.

Relationship between absorbed dose and SUV derived from SPECT/CT imaging and dose-response in patients with neuroendocrine tumors treated with [¹⁷⁷Lu]Lu-DOTA-TATE.

Authors: Liu, Fei Yang, Hongxing Zhang, Jianping et al.

Source: EJNMMI Research. 2/25/2026, Vol. 16 Issue 1, p1-12. 12p.

Efficient 68 Ga Labeling of a B7-H3-Targeting Affibody Molecule via Acyclic Tris(hydroxypyridinone) Chelator: Effects on Biodistribution in a Preclinical Model.

Authors: Tolmachev, Vladimir Herlina, Amelinda Janice Papalanis, Eleftherios et al.

Source: International Journal of Molecular Sciences. Feb2026, Vol. 27 Issue 4, p1713. 17p.

Generative restoration for cardiac PET attenuation correction: a two-stage 3D DDIM framework optimizing fidelity and clinical controllability.

Authors: Deng, Junhang Sun, Hao Wang, Haifeng et al.

Source: EJNMMI Physics. 2/2/2026, Vol. 13 Issue 1, p1-17. 17p.

Quantitative PSMA PET Biomarkers for Predicting Response to ¹⁷⁷Lu-PSMA Therapy in Prostate Cancer: A Systematic Review and Meta-analysis.

Authors: Kiani, Iman Siri, Mohammad Amin Babaei, Mahan et al.

Source: Journal of Nuclear Medicine. Jun2026, Vol. 67 Issue 6, p929-935. 7p.